Imexpharm Corporation (HOSE:IMP)
54,000
+100 (0.19%)
At close: Feb 27, 2026
12.50% (1Y)
| Market Cap | 8.32T |
| Revenue (ttm) | 2.44T |
| Net Income (ttm) | 304.39B |
| Shares Out | 154.01M |
| EPS (ttm) | 1,976.44 |
| PE Ratio | 27.32 |
| Forward PE | 22.65 |
| Dividend | 500.00 (0.93%) |
| Ex-Dividend Date | Jun 9, 2025 |
| Volume | 44,747 |
| Average Volume | 34,255 |
| Open | 53,900 |
| Previous Close | 53,900 |
| Day's Range | 53,900 - 54,200 |
| 52-Week Range | 36,100 - 56,500 |
| Beta | 0.69 |
| RSI | 60.08 |
| Earnings Date | Jan 16, 2026 |